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Abstract  14 
Synthetic hydrolytically degradable polyesters have seen widespread translation into a variety of 15 
clinical and biomedical settings; finding use as cell culture systems, drug delivery systems, tissue repair 16 
scaffolds, and medical devices. This success is owed in part due to their biocompatible nature and 17 
tuneable degradation profile. However, the lack of adhesion moieties limits the capacity of the 18 
polyesters to interact with cellular material and as such hampers their effectiveness within these 19 
applications. Several physical and chemical post-modification techniques have been developed to 20 
insert adhesion moieties; however, the nature of these methods remains complex and troublesome 21 
for translational medicine. To combat this flaw, we present a novel prefunctionalization method for 22 
the generation of poly (lactic-co-glycolic acid) PLGA microparticles with integrated adhesion moieties 23 
as a proof-of-principle. This strategy promotes surface cell adhesion at physiological conditions 1 
without the requirement for further post-modification. The basis of the prefunctionalization method 2 
was to utilise the 2-2-dimethylaminoethanol as an initiator in a standard bulk Ring Opening 3 
Polymerization process to obtain PLGADMAE polymers. The resultant polymers were subsequently used 4 
in the fabrication of the microparticles, via membrane emulsion. This process allowed control over the 5 
morphology and size distribution of the microparticles. The surface cell adhesive properties of the new 6 
PLGADMAE microparticles were investigated via co-culture with Adipose-Derived Stem Cells. Scanning 7 
Electron Microscopy showed that the new PLGADMAE microparticles readily promote adhesion of the 8 
ADSCs at physiological conditions. LDH and LIVE/DEAD assays demonstrated that the surface 9 
functionalised PLGADMAE microparticles maintained a low toxicity profile compared to the unmodified 10 
PLGA microparticles. Both thermogravimetric and differential scanning calorimetric analysis 11 
confirmed that the bulk properties of the polymer remained unchanged compared to the control 12 
PLGA. Gel Permeation Chromatography and Scanning Electron Microscopy imaging showed that the 13 
degradation profile of the new PLGADMAE was enhanced compared to that of standard PLGA polymers. 14 
This novel prefunctionalization strategy eliminates the need for post-modification and could evolve 15 
rapidly to develop biodegradable biomaterials with enhanced cell adhesion and tuneable surface 16 
chemistry to allow greater control and/or maintain interaction with living cells and tissues. The 17 
implication of this new approach would be far reaching in the field of cell delivery, cell expansion, 18 
tissue engineering and regenerative medicine. 19 
 1 




  6 
Introduction 1 
Synthetic hydrolytically degradable polyesters such as poly (lactic acid) (PLA), poly (glycolic acid) (PGA), 2 
poly (lactic-co-glycolic acid) (PLGA), and poly(caprolactone) (PCL) are one of the most widely used 3 
polymers in the biomedical field, with applications including but not limited to cell culture systems, 4 
drug delivery systems, tissue repair scaffolds and medical devices[1-3]. The terminal functional groups 5 
such as ester and acid of polyester polymers play an important role in modulating the degradation 6 
and release profiles of polyester polymers and have been widely used in the context of controlled drug 7 
delivery systems[4, 5]. Their biologically inert nature and tuneable degradation profile coupled with 8 
their straight-forward and cost-effective production makes these polymers appealing both for 9 
research and commercial usage[6]. Microparticles (MPs) are one such usage of these polyester 10 
polymers[7]. Despite the success of the polyester and associated MPs, their applications in the 11 
development of more advanced tissue culture and cell delivery platforms have been hampered by 12 
their lack of cell adhesion moieties, which is largely due to the hydrophobic surface of these 13 
polymers[8, 9]. Consequently, the development of strategies to modify the surface of these polymers 14 
has garnered significant interest.  15 
Several physical and chemical modification techniques have been established to address these issues. 16 
Examples of physical modifications included blending or surface coating of natural polymers 17 
containing cell adhesive sites (e.g., laminin, fibronectin, and vitronectin)[10-14]. In regard to chemical 18 
modifications, a popular strategy is the process of aminolysis to generate an active site on the polymer 19 
surface[15, 16]. This site acts as a target for subsequent activation and conjugation with small 20 
molecules such as arginine-glycine-aspartic acid (RGD) peptides[17, 18]. More recently, advanced 21 
surface-grafting of cationic polymers to a preformed polyester was reported using a specialist chain 22 
transfer molecule and living polymerization techniques[19-22]. Despite the progress in the 23 
development of post modification techniques the nature of these methods remains complex, 24 
challenging, and troublesome for translational medicine.  25 
In this work we aimed to introduce a new and practical methodology for surface modification of 1 
polyester based materials that can readily promote cell adhesion at physiological conditions. We were 2 
particularly interested in strategies that allow the insertion of cell adhesion moieties such as small 3 
cationic functional groups into the structure of the polyester polymers in a one-step process. The 4 
rationale for using cationic groups was to enable interaction and adhesion with polyanionic cell 5 
membranes. In specific, we wanted to replace any post-functionalization methods. 6 
Previous work by our group reported the prefunctionalization approach for surface modification of 7 
PCL MPs with azide functional groups, which were subsequently utilised for conjugation of a model 8 
protein via a copper-free click chemistry reaction at physiological conditions. This mechanism elicited 9 
a significantly higher and faster conjugation of the model protein on the surface of the 10 
prefunctionalised PCL MPs[23]. We decided to take this approach forward and so synthesised 11 
polyester polymers with cell adhesion moieties in the form of heterobifunctional tertiary amines.  12 
To examine this method, we co-polymerised lactide and glycolic monomers from 2-13 
dimethylaminoethanol (tertiary amine) (DMAEtOH) as an ROP initiator to generate a PLGADMAE 14 
polymers with terminal dimethylaminoethyl (DMAE) groups. We chose the DMAEtOH since the pKa 15 
value of this tertiary amine is higher than that of physiological pH and expected to be positively 16 
charged, which in turn, may promote interaction with polyanionic cell membranes[24, 25]. 17 
Subsequently, PLGADMAE MPs were fabricated via membrane emulsion allowing relative control over 18 
the particle size and size distributions. In order to demonstrate the utility of the PLGADMAE MPs for cell 19 
culture use, we targeted the MPs size to be equal to or greater than 100 micrometres. This is 20 
approximately within the size range of commercially available MPs (namely microcarriers) which are 21 
primarily used in suspension cell culture as a substrate for cell expansion purposes. 22 
We analysed the PLGADMAE MPs for surface adhesion with the clinically relevant cell type ADSCs and 23 
compared their performance against unmodified PLGA MPs under the same culture conditions. We 24 
rationalised that changing terminal functional groups may impact the bulk properties of the polymers. 25 
Therefore, we investigated the effect of the terminal DMAE groups on the degradation and 1 
cytotoxicity profiles of the newly synthesised PLGADMAE polymers and compared it to that of the 2 
unmodified PLGA MPs. We also examined the macroscopic and molecular degradation of the new 3 
PLGADMAE MPs under culture conditions, using GPC and SEM analyses. These studies were undertaken 4 
to demonstrate the advantage of prefunctionalization of PLGADMAE polymers with terminal DMAE 5 
groups to promote cell adhesion without compromising the already attractive bulk properties, 6 
cytotoxicity, or degradation profiles of the PLGA polymer. 7 
This new strategy of one-step prefunctionalization of polyester polymers, exemplified via PLGADMAE 8 
synthesis using a standard bulk ROP process to introduce cell adhesion moieties, resulted in MPs with 9 
surfaces that promote cell attachment at physiological conditions, which can be considered as a 10 
significant step forward. This new method can address the shortcomings, namely, the lack of cell 11 




Reagents were used as purchased, unless stated otherwise. Dimethylaminoethanol (DMAEtOH; ≥ 99.5 16 
%); citric acid (≥ 99.5); polyvinyl alcohol (PVA; Mw 13,000 – 23,000, 87 - 89 % hydrolyzed); sodium 17 
chloride (NaCl; ≥ 99.5 %); Hoechst 33258 fluorescent dye; Paraformaldehyde were purchased from 18 
Sigma-Aldrich (UK). D, L-lactide (> 98.0 %), glycolide (> 98.0 %) and tin (II) 2-ethylhexanoate (> 85.0 %) 19 
were purchased from Tokyo chemical industry. Tetrahydrofuran (THF; ≥ 99.9 %); dichloromethane 20 
(DCM; ≥ 99.5 %); acetone (≥ 99.8 %), methanol (≥ 99.8 %); 2-propanol (≥ 99.7 %) were purchased from 21 
VWR International. 1-Propanol (anhydrous, 99.9%) was purchased from Alfa Aesar™. Deuterated 22 
chloroform (CDCl3; ≥ 99.8 %) was purchased from Acros Organics. Sodium hydroxide (NaOH; ≥ 99.0 %) 23 
was purchased from Merck Millipore. Adipose tissue-derived stem cells (ADSCs), ADSCs basal media 24 
and supplements fetal bovine serum (FBS; 10 %), L-glutamine (1 %), gentamicin-amphotericin (0.1 %); 25 
trypsin; trypsin neutralizing solution were purchased from Lonza. Phosphate Buffered Saline (PBS) 1 
tablets; trypan blue; were purchased from Thermo Fisher Scientific. CellTiter 96® AQueous One 2 
Solution Cell Proliferation (MTS) Assay was purchased from Promega. CyQUANT™ Lactate 3 
dehydrogenase (LDH) Cytotoxicity Assay; LIVE/DEAD™ Viability/Cytotoxicity Kit, for mammalian cells 4 
were purchase from Thermo Fisher Scientific.  5 
Methods 6 
Synthesis of unmodified PLGA and PLGADMAE Polymers  7 
The PLGADMAE polymer was synthesized via the standard bulk ring opening polymerization technique. 8 
First, a round bottom flask was degassed with nitrogen gas for 1 h into which the monomers D, L-9 
lactide (11.3 g, 78.5 mmol), glycolide (9.1 g, 78.5 mmol) and the initiator 2-dimethylaminoethanol (0.1 10 
g, 1.1 mmol, 117 µL) were added and the flask was tightly sealed with a septum. The mixture was then 11 
gradually heated to 140 °C under stirring and nitrogen conditions. Once the mixture was completely 12 
dissolved, the catalyst tin (II) 2-ethylhexanoate (0.046 g, 0.1 mmol) was added via a needle. The 13 
mixture was left to stir at the speed of 250 rpm and 140 °C for further 48 h. After this time, the reaction 14 
mixture was then cooled down and solidified polymer was collected from the flask. To directly 15 
compare the PLGADMAE to unmodified PLGA, the latter was also synthesised under the same conditions 16 
except the DMAE was replaced with anhydrous 1-propanol as ROP initiator. A short oligo PLGADMAE 17 
was also synthesized and purified, under the same condition, and characterised by 1H NMR to 18 
elucidate the insertion of the DMAE group into the structure of the PLGA polymer. Samples from PLGA 19 
and PLGADMAE polymers were collected for subsequent analyses.  20 
Fabrication of PLGA and PLGADMAE Microparticles 21 
The PLGA and PLGADMAE MPs were synthesised via the membrane emulsion technique, following a 22 
previously published protocol by our group using the Micropore LDC-1 dispersion kit (Micropore 23 
technologies, UK)[23]. Briefly, a continuous stabilizing solution was prepared by mixing PVA (20 g) and 24 
NaCl (26 g) in ultrapure water (1.8 L) under stirring and at 40 °C for overnight until complete 1 
dissolution. The solution was then vacuum filtered using a Buchner funnel. To this solution, 46 g of 2 
DCM solvent was gradually added and stirred for 1 h. The PLGA and PLGADMAE (12.5 % w/v) polymers 3 
were dissolved separately in DCM (14 mL) to produce the organic phase. To generate emulsion 4 
droplets, the organic phase was injected via a stainless-steel hydrophilic ring membrane (40 µm pore 5 
size) into the continuous phase (130 mL) at a rate of 0.50 mL/min, and preadjusted stirring speed of 6 
600 rpm. The formed droplets were collected and transferred into a beaker. The mixture was then left 7 
to stir overnight under fume hood condition to evaporate the organic phase, resulting in the formation 8 
of solidified MPs. The MPs were then collected and transferred into a Buchner funnel and washed 9 
with ultrapure water several times to remove the residual of the PVA polymers. Finally, the MPs were 10 
collected via centrifugation at 1000 rpm for four minutes. The final MPs were freeze dried to obtain a 11 
loose dry powder and stored in a cold dry condition until further use.  12 
Characterisation  13 
The molecular weight of PLGA and PLGADMAE were calculated using Gel Permeation Chromatography 14 
(GPC) analysis. The PL-GPC 50 was used in conjunction with a refractive index detector. A guard 15 
column (PLgel 5 µm MiniMIX-C, 50⁄ 4.6 mm) was connected with two columns (PLgel 5 µm Mixed-D, 16 
300⁄ 7.5 mm) and maintained at 30 °C. The GPC machine was calibrated using Agilent EasiVial GPC 17 
poly methyl methacrylate calibration standards (PMMA; molar mass range: 3 x 105 – 6 x 105 Da). To 18 
perform the analysis, a sample of PLGA and PLGADMAE (approx. 1mg/ml) was dissolved in THF solvent 19 
(HPLC grade) and injected at a flow rate of 1 mL/ min. The data were collected and analyzed using 20 
CIRRUSTM data stream software.  21 
(1H NMR) magnetic resonance spectroscopy was used to confirm the polymer structures, using the 22 
Bruker 400 MHz spectrometer. To do this, a small quantity of the PLGA and PLGADMAE polymers were 23 
dissolved separately in deuterated chloroform (CDCL3; 1.2 mL) and 1H NMR with average of 16 scans 24 
were recorded for each sample. The data was analysed using TopSpinTM NMR software v.4 and 1 
processed with MestReNova software v. 6.0.2-5475.  2 
Thermogravimetric gravimetric analysis (TGA) was performed on the PLGA and PLGADMAE polymers. 3 
Approximately 1-5 mg of the polymers were placed in tared unsealed standard aluminium pans (TA 4 
instruments). The data was recorded under nitrogen atmosphere and analyzed using a TGA 5500 5 
analyzer (TA Instruments). The samples were heated from room temperature to 400°C and at heating 6 
a rate of 10°C/min. Two set of data were collected including weight loss (%) profile and derivative 7 
weight (%/°C) as a function of temperature. All measurements were recorded using TRIOS software. 8 
Differential Scanning Calorimetry (DSC) analysis was performed on the polymers to determine the 9 
glass transition temperature (Tg). Approx. 1-5 mg of the polymers were placed in sealed standard 10 
aluminium pans (TA instruments), and an empty sealed standard aluminium pan (TA instruments) was 11 
used as a reference. The data was collected using a DSC 2500 analyser (TA Instruments) and under 12 
nitrogen atmosphere. To do this, the samples were equilibrated first at -10°C, and then heated to 13 
150°C at a rate of 10°C/min, then cooled to -10°C at a rate of 10°C/min. Finally, the samples were 14 
heated again to 150°C at the same heating rate of 10°C/min (to obtain three cycles in total). The Tg of 15 
the polymers were obtained from the second heating event to remove any interference from the 16 
residual moisture in the samples. A heat flow measurement (W/g) as a function of increasing 17 
temperature profile were then obtained. All measurements were recorded using TRIOS software. 18 
Microparticle size and size distribution analysis  19 
The mean particle size and particle size distributions for PLGA and PLGADMAE MPs were measured using 20 
optical EVOS XL Core phase contrast microscope (Thermo Fisher Scientific). To calculate the span, the 21 
average diameter (D) in µm of solidified microparticles was calculated from circular 2D optical surface 22 
area using the oval tool from ImageJ software. This tool was used to select the circumference of the 23 
particles. 20 representative images of PLGA and PLGADMAE MPs were taken at 20X magnification, and 24 
a minimum of 40 particles per image were used for data analysis. Span was then calculated from the 25 
D10, D50 and D90 corresponding to the diameters at 10, 50 and 90 percentiles, respectively. The D90 1 
were subtracted from D10 values and the result was then divided by D50. Distribution histograms 2 
were created with SPSS statistical software (IBM Corp. Released 2020. IBM SPSS Statistics for 3 
Windows, Version 27.0. Armonk, NY: IBM Corp) to illustrate the dispersity of MPs. 4 
The morphology of the MPs was also analysed by Scanning Electron Microscopy (SEM) imaging. Briefly, 5 
freeze dried MPs were loaded onto the aluminium stubs with carbon tabs and then gold coated with 6 
a Quorum Technologies Polaron Gold Sputter Coater (rotary stage, 30sec, 20mA, 2.2kV, average 7 
distance from Au target: 55mm). The MPs were then imaged using a Zeiss Gemini SEM 300 at an 8 
accelerating voltage of 2 kV.  9 
To investigate if the UV sterilization process had any impact on structure and morphology of the MPs, 10 
confirmatory (1H NMR) and SEM analyses were performed on the MPs before and after UV sterilization 11 
process. The samples were analyzed following the protocol described earlier for each technique. To 12 
further supplement the analysis, Fourier-Transform Infrared Spectroscopy (FT-IR) was conducted on 13 
the PLGA and PLGADMAE MPs before and after UV irradiation. FT-IR spectra were recorded on a Bruker 14 
Vertex 70V FTIR Spectrometer equipped with Golden Gate™ Heat-enabled ATR accessory (Specac LTD, 15 
UK) in absorption mode against wavenumber.  The OPUS software was used to record the spectra at 16 
4 cm-1 resolution using 32 scans. The wavenumber range of the spectra was selected from 550 to 4000 17 
cm -1.  18 
 19 
Cell Culture 20 
Human Adipose-Derived Stem cells (ADSCs) (PT-5006, Lot number 0000439846) were purchased from 21 
Lonza (statement from the supplier confirm the cells were obtained under ethical conditions with the 22 
donor consent and tissue acquisition letter is available upon request). Cells were received in passage 23 
one, expanded to passage three using monolayer culture condition following the manufacturer 24 
protocols (Catalogue number PT-4505; Lonza). Cells were cultured in ADSCs Basal Media 1 
(supplemented with 10% FBS, 1% of L-glutamine, and 0.1% of gentamicin amphotericin) and 2 




Cell attachment  7 
The freeze dried PLGA and PLGADMAE MPs were sterilised by standard UV irradiation (for 1.5 h). The 8 
MPs powder was loaded into a glass vial and rotated on a laboratory roller to maximise the light 9 
exposure. The sterilised MPs were prepared in cultured condition. Briefly, 10 mg of the freeze-dried 10 
MPs were resuspended in 1 mL of the complete cell culture media for 12 h at room temperature. 11 
Following this step, the media was removed from the MPs suspension via centrifugation at 1000 rpm 12 
for four minutes followed by gentle aspiration of the supernatant, leaving the conditioned MPs in 13 
place.  14 
Two methods were followed to study the cell attachment to the MPs. In (Method 1), 20,000 cells 15 
suspended in 250 µL complete media were mixed with 10 mg of the MPs to obtain a final 16 
concentration of 2x103 cells.mg-1 of MPs (the calculated surface area of the MPs equals to 0.4 cm2.mg-17 
1). This mixture was directly transferred into the well of a 24-well cell culture plate and topped up to 18 
1 ml with cell culture media. In (Method 2), we followed an in house developed protocol to maximise 19 
cell attachment by mixing the MPs and cells in closer proximity. Cells and MPs were mixed using the 20 
same concentrations as before. From this mixture, 20 µL of the cells and MPs mixture were pipetted 21 
(wide orifice pipette tips were used) onto an inverted lid of a 60 mm diameter petri dish, which was 22 
gently flipped over and placed on top of the petri dish containing 5 mL of PBS in order to maintain a 23 
humidified environment. Following 24 h incubation and under the described conditions, all the 24 
droplets collected from each Petri dish lid were transferred into one well of a 24-well tissue culture 1 
plate, which was previously filled with 500 µl of cell culture media. After the transfer of the droplets, 2 
each well was topped up to 1 mL with complete media. The mixture of cells and MPs was maintained 3 
in a humidified atmosphere with 5% CO2 and 37 oC for predetermined time intervals. All experiments 4 
were conducted in static conditions and the cell culture media was refreshed every three days 5 
(approximately, 600 µL of cell culture media was gently removed and replaced by fresh media).  6 
 7 
Cytotoxicity study  8 
ADSCs were cultured on PLGA and PLGADMAE MPs, as previously described (method 2), in 24-well cell 9 
culture plates for 1, 5, 7, and 14 days, and the LDH analysis was performed following the 10 
manufacturer’s instructions. Briefly, 50 µl of cell culture media was withdrawn from tissue culture 11 
plates and mixed with CyQUANT™ LDH Cytotoxicity Assay Kit LDH reagent in a 1:1 ratio. Following 30 12 
minutes incubation at room temperature and storage in a dark place, LDH stop solution was added. 13 
The absorbance values were measured at 490 and 680 nm with a microplate reader (CLARIOSTAR; 14 
BMG Labtech). Background absorbance at 680 nm was subtracted from the 490 nm absorbance. Cell 15 
culture media without cells was used as a blank.  16 
Phase contrast microscopy was used to monitor all cell culture conditions. Representative images 17 
were taken 1, 5, 7 and 14 days after culture using an EVOS XL Core (Thermo Fisher Scientific) phase 18 
contrast microscope. Images were taken with 10X or 20Xmagnification and processed using ImageJ 19 
software. 20 
Live/Dead assay 21 
ADSCs were cultured on PLGA and PLGADMAE MPs in 24-well cell culture plates (method 2) for 1, 7, and 22 
14 days. Approximately, 600 µL of media was removed from the culture dishes and MPs were washed 23 
once with 600 µL of PBS. Then, the PBS was gently removed. Freshly prepared Calcein AM and 24 
Ethidium homodimer-1 solution (2 and 4 µM, respectively) was prepared following manufacturer’s 1 
instructions, added to the cells and MPs mixture, and incubated for 40 min in the dark at room 2 
temperature. Next, imaging was performed using a Zeiss Axiovert 200M microscope using Axiovision 3 
software. Images were taken with a 20x magnification Plan-Neofluar (NA 0.5) objectives and a Zeiss 4 
AxioCam HRm CCD camera. Fluorescence was excited either at 494 – 517 nm (Calcein) or 528 – 617 5 
nm (Ethidium homodimer-1). Merged images of Calcein (green), Ethidium homodimer-1 (red) and 6 
Bright Field were created in Image J software. Live and Dead cells were counted in every picture, using 7 
a minimum of three random locations per sample. 8 
Cell attachment analysis 9 
SEM imaging was used to investigate cell attachment onto the PLGA and PLGADMAE MPs. The ADSCs 10 
were cultured on PLGA and PLGADMAE MPs, as previously described in 24-well cell culture plates 11 
(method 2) for 7 days (this was considered a midpoint between start of the culture and sufficient cell 12 
attachment and growth). Approximately, 600 µL of media was removed, and the remaining cells and 13 
MPs mixture were fixed with freshly prepared 4 % paraformaldehyde in PBS for 30 min at room 14 
temperature. Fixed cells and MPs mixture were washed three times with PBS and centrifuged at 1000 15 
rpm for four minutes, which were collected and freeze dried. The freeze dried powder was loaded 16 
onto aluminium stubs with carbon tabs. The samples were gold coated with a Quorum Technologies 17 
Polaron Gold Sputter Coater (rotary stage, 30sec, 20mA, 2.2kV, average distance from Au target: 18 
55mm) and subsequently imaged using a JSM 5900LV (JEOL) SEM at an accelerating voltage of ~10 kV. 19 
Degradation study  20 
PLGA and PLGADMAE MPs were prepared as previously described. The MPs were immersed in 2 mL of 21 
PBS, incubated at 37 °C in a water bath for 7, 14, and 21 days, and samples were collected and freeze 22 
dried.  23 
First, the macroscopic and morphological changes were studied using SEM, samples were prepared 1 
following the same protocol as described earlier. SEM images of the MPs were acquired using a Zeiss 2 
Gemini SEM 300 at an accelerating voltage of 2 kV.  3 
Secondly, the molecular degradation of the MPs was examined using GPC. The freeze dried MPs were 4 
dissolved in 2 mL of THF (HPLC grade) for 24h at room temperature. After complete dissolution, the 5 
samples were injected and analysed using the previously described protocol. The shifting in the 6 
number-average molecular weight (Mn) of the PLGA and PLGADMAE MPs were analyzed and compared 7 
to that of the undegraded polymers.  8 
 9 
Statistical analysis  10 
For the particle size and particle size distribution, frequency distribution histograms were created with 11 
SPSS statistical software to illustrate the dispersity of microparticle diameter with associated Span 12 
values. A bar chart was plotted to compare the mean particle size between PLGA and PLGADMAE MPs 13 
representing the mean particle size (µm) ± SD (n = 20 representative images of PLGA and PLGADMAE 14 
MPs). A two-tailed unpaired t test was used to assess significant differences between the particle size 15 
of both groups. ns: non-significant. In regard to the cytotoxicity study using the LDH assay, the data 16 
are presented as optical density values (OD) ± SD (n = 3 independent cell culture replicates). 17 
Differences between groups were assessed via a two-way ANOVA with a Tukey’s multiple comparison 18 
test. Ns: non-significant, * p=0.03, ***p<0.0002, ****p < 0.0001. In the Live/Dead staining 19 
experiment, data are presented as the average of counted cells per field ± SD (n=3 independent 20 
technical cell culture replicates) in three random locations, therefore using a total of 9 images per 21 
sample. Ns: non-significant.  22 
 23 
 24 
Results and discussion  1 
The overarching aim of this work was to address the lack of cell adhesion in hydrolytically degradable 2 
polyester polymers. It is known that the presence of cationic functional groups in the structure of 3 
synthetic materials can facilitate interaction with polyanionic cell membranes[26, 27]. Therefore, we 4 
set out to insert cationic functional groups into the terminal end of these polymers via the ROP 5 
technique. To achieve this strategy, we chose to use 2-dimethylaminoethanol (DMAEtOH) as a 6 
heterobifunctional initiator. The hydroxyl group of DMAEtOH was used to initiate the ROP of the 7 
polymers to insert tertiary amine groups. We hypothesised that tertiary amine groups on the terminal 8 
end of the synthesised polymers would become protonated at physiological conditions and thus can 9 
display positive charges to interact with cell membranes. We compared this new polymer to a 10 
standard PLGA polymer (control) synthesised under the same condition but with 1-propanol as the 11 
initiator (Figure 1 A).  12 
The theoretical feeding ratio and ROP polymerization conditions for both PLGA and PLGADMAE polymers 13 
are summarised in (Table 1). The GPC analysis showed that the number-average molecular weight 14 
(Mn) and polydispersity (PDI) of both PLGA and PLGADMAE polymers were comparable as measured 15 
against the PMMA standards (See Figure S1 A-B, Supporting Information (SI)). The Mn for the PLGADMAE 16 
measured was 26,400 Da with PDI (Ð)m 1.6 and a yield of > 90 %, compared to that of the PLGA polymer 17 
with an Mn of 26,563 Da with PDI (Ð)m 1.6 and also a yield of > 90 % (Table 1).  18 
Table 1. PLGA and PLGADMAE synthesis feed ratio (mol%), relative molecular weight (g.mol-1), 19 
polydispersity and yield (%) as measured by GPC analysis and using PMMA as standards.  20 
Polymer Theoretical Feed ratio (mol %) 
Relative 
molecular weight 
(g/mol) Dispersity Yield (%) 
Lactide Glycolide Initiator Mn Mw 
PLGA 71 71 1 26,563 42,980 1.6 > 90 
PLGADMAE 71 71 1 26,400 41,381 1.6 > 90 
 21 
Next, the chemical structures of the PLGA and PLGADMAE polymers were confirmed by 1H NMR analysis. 1 
The spectra for both polymers confirmed the main structure and peaks for the repeating monomer 2 
units of lactic acid and glycolic acid. We calculated the composition to confirm the 50/50 ratio, which 3 
was measured by integrating the peaks of the two repeating units. The 1H NMR spectra of both 4 
polymers showed the typical peak characteristics for the monomers with chemical shifts detected at 5 
5.2 ppm (CH, 1H) and 1.6 ppm (CH3, 3H) for lactic acid, and at 4.8 ppm (CH2, 2H). for glycolic acid. A 6 
short oligo PLGADMAE was also synthesized and its structure was confirmed by 1H NMR showing the 7 
successful initiation of the PLGA polymer from the DMAE initiator, (See Figure S2, Supporting 8 
Information (SI)). 9 
 10 
Figure 1 Schematic illustration of the one step synthesis and fabrication of the prefunctionalised 11 
PLGADMAE MPs versus the control PLGA MPs. (A) Standard ROP of the D, L Lactide and Glycolide 12 
monomers, using Tin (II) as catalyst and heating at 140 oC for 48 h under nitrogen condition. (B) 1 
Fabrication of PLGA or PLGADMAE MPs via the membrane emulsification process. 2 
Next, the thermal properties of the polymers were analyzed using both thermogravimetric (TGA) and 3 
differential scanning calorimetry (DSC) to investigate whether the insertion of the new DMAE terminal 4 
functional groups affects the physicochemical properties of the new prefunctionalised PLGADMAE 5 
polymer. As can be seen in (Figure S3 A, SI), there was a 50% weight reduction at 287 °C and 285 °C 6 
for PLGA and PLGADMAE, respectively. The derivative weight supported these findings; demonstrating 7 
that the maximum rate of degradation temperature (MRDT) between the two polymers were likewise 8 
similar. 9 
 A similar observation was also recorded from the DSC analysis which was used to determine the glass 10 
transition temperature (Tg) of the two polymers (Figure S3 B, SI). The results showed that both 11 
polymers possess a similar Tg at 44 °C, this value is broadly similar to the reported Tg for PLGA polymers 12 
having 50:50 ratio of composition of lactic acid to glycolic acid units[28]. These analyses confirmed 13 
that the thermal profiles were comparable with negligible differences between the two polymers.  14 
In the next step, MPs were fabricated via the single oil-in-water membrane emulsion technique (Figure 15 
1 B). We targeted the diameter of the MPs to be equal to or greater than 100 µm. The rationale behind 16 
this was that the range is relatively close to that of commercially available MPs, which are used as a 17 
cell culture substrate in suspension cell culture systems. 18 
The PLGA and PLGADMAE MPs were both prepared under the same emulsification parameters and 19 
polymer concentrations. Preliminary work (data not shown) suggested that a polymer concentration 20 
of 12.5% w/v (adjustable based on the polymer molecular weight) was sufficient to achieve MPs within 21 
the target size range. Under the described conditions (see the method section), MPs were successfully 22 
fabricated from both polymers. The comparative size and morphology of fresh droplets, solidified 23 
MPs, and freeze dried MPs derived from the PLGA and PLGADMAE polymers were assessed using phase 24 
contrast microscopy (Figure 2, A) and SEM imaging (Figure 2, B). The phase contrast and SEM imaging 25 
confirmed the successful formation of spherical MP morphologies. Further analysis of the phase 1 
contrast images demonstrated that the distribution of the particle sizes was unimodal and possessed 2 
little variance (Figure 2, C), suggesting near uniform particle sizes distribution for both PLGA and 3 
PLGADMAE MPs. The calculated Span values from the phase contrast imaging were also compared 4 
between the PLGA and PLGADMAE MPs which showed a value of 0.3 suggesting a narrow particle size 5 
distribution. Furthermore, the mean particle size and relative standard deviation were also plotted as 6 
bar charts in (Figure 2, C), indicating that there was no significant difference between the two MPs 7 
groups. These data suggest that the prefunctionalised polymer did not alter the size or the morphology 8 
of the MPs. 9 
 10 
Figure 2: There are no significant differences in the morphologies or size distribution between the 11 
PLGA and PLGADMAE Microparticles. (A) Phase Contrast imaging of freshly prepared (left) and solidified 12 
(right) PLGA and PLGA DMAE microparticles. Scale bar is 100 µm (10X magnification). (B) SEM of freeze 13 
dried PLGA and PLGA DMAE microparticles. Scale bar is 100 µm. (C) Frequency histograms, Span values 14 
and accompanying information regarding the size distribution and mean particle size comparison of 15 
PLGA and PLGADMAE microparticles. Mean particle size comparison between PLGA and PLGADMAE 1 
microparticles is shown as bar charts. Data is presented as mean particle size (µm) ± SD (n = 20 2 
representative images). A two-tailed unpaired t test statistical analysis was applied. Ns: non-3 
significant.  4 
With the uniformity of the MP size and morphology between the two polymers established, we next 5 
sought to address whether the surface functionalization affected the cytotoxicity profiles. Prior to the 6 
cytotoxicity assays, the morphology and chemical properties of the PLGA and PLGA DMAE microparticles 7 
were investigated before and after UV sterilization, using SEM imaging, FT-IR and 1H NMR. The results 8 
confirmed that no changes occurred as a result of the sterilization (Fig S4, SI).  9 
Two methods were investigated to evaluate the efficiency of seeding ADSCs onto the MPs.  In (Method 10 
1) followed a standard protocol by mixing cells with the MPs in the 24-well plate tissue culture 11 
plastic[29], whereas in (Method 2), cells were mixed with MPs in form of hanging droplets for 24 h to 12 
enhance the exposure of the cells to the MPs in closer proximity. As can be seen in (Figure S5, SI), the 13 
nuclei staining and phase contrast imaging suggested that the aggregation of the ADSCs with the MPs 14 
were significantly higher in (Method 2) compared to that of (Method 1). Therefore, we have followed 15 
method 2 for the rest of the work.  16 
We performed the cytotoxicity study on the MPs co-cultured with ADSCs, using LDH and LIVE/DEAD 17 
assays, and the results were analyzed at day 1, 5, 7 and 14 post culture. The absorbance value of 18 
Formazan (directly proportional to the amount of LDH released into the medium) was recorded as 19 
function of time post culture. In (Figure 3, A), we detected a significantly lower concentration of LDH 20 
released into the medium of the PLGADMAE MPs group at day 1 post culture, compared to that of the 21 
PLGA, which infers a higher survival rate. At this point, the differences observed in the LDH 22 
concentration between the two group was probably due to the differential attachment of the ADSCs 23 
to the PLGA and PLGADMAE MPs within the first 24 h. However, the differences in LDH concentrations 24 
observed between the two groups at day 5, 7 and 14 post culture were not statistically significant, 25 
which was probably because the remaining cells were either adhered to the surface of the PLGADMAE 1 
MPs or to the surface of the tissue culture plastic when co-cultured with the unmodified PLGA MPs. 2 
This was supported by the fact that the phase contrast imaging showed that the ADSCs were attached 3 
to the PLGADMAE MPs, whereas in the unmodified PLGA MPs group, cells were mostly adhered to the 4 
tissue culture plastic (Fig S6, SI).  5 
Taken together, these data suggest that following the successful attachment and survival advantage 6 
in the first 24 h period, the PLGADMAE MPs maintained the already desirable low toxicity profile of PLGA 7 
polymers. Furthermore, the LIVE/DEAD viability assay indicated that there was no significant 8 
difference to the viability of the cells co-cultured with either PLGADMAE or PLGA MPs over the cultured 9 
time period (Figure 3, B-C). 10 
 1 
Figure 3: PLGADMAE microparticles retain a low cytotoxicity profile and is comparable to non-2 
functionalised PLGA microparticles. (A) LDH assay performed on ADSCs in the presence of PLGA or 3 
PLGADMAE MPs, analysed at days: 1,5,7, and 14 post-culture. Data are presented as optical density 4 
values (OD) ± SD (n = 3 independent cell culture replicates). Differences between groups were assessed 5 
via a two-way ANOVA with a Tukey’s multiple comparison test. Ns: non-significant, * p=0.03, 6 
***p<0.0002, ****p < 0.0001. (B) Representative fluorescent images showing the LIVE (Calcein AM- 7 
green)/DEAD (ethidium homodimer-1- red) staining of the co-cultured cells with the MPs at different 8 
time intervals. Scale bar is 100 µm (20X magnification). (C) Average number of cells per field of view 1 
that were classified as either alive or dead. Data are presented as the average of counted cells per field 2 
± SD (n=3 independent technical cell culture replicates) in three random locations, therefore using a 3 
total of 9 images per sample. Ns: non-significant. 4 
Although the previous assays showed that the PLGADMAE MPs were well tolerated when co-cultured 5 
with the ADSCs, more investigations were required to show that cells can attach to the surface of the 6 
PLGADMAE MPs at physiological conditions. Thus, ADSCs were co-cultured with PLGA and PLGADMAE MPs 7 
for 7 days and surface cell attachments were investigated using SEM imaging (Figure 4). A pilot study 8 
(data not shown) demonstrated that day 7 was the most appropriate timepoint to image the 9 
attachment of the ADSCs to the MPs as it represented a midpoint between early cell attachment and 10 
over confluent cell culture conditions. It was strongly evident from the analysis that the PLGADMAE MPs 11 
readily attached to the co-cultured ADSCs, (Figure 4, bottom row), compared to no or poor attachment 12 
of the ADSCs to the PLGA MPs (Figure 4, top row). Once again, the SEM imaging suggested that the 13 
ADSCs were predominantly attached to the tissue culture plastic when using PLGA MPs (Figure 4, 14 
bottom row). 15 
In addition, the ADSCs attached to the PLGADMAE MPs had different morphologies compared to those 16 
co-cultured with the PLGA MPs. Cells attached to the PLGADMAE MPs adopted elongated morphologies; 17 
gripping and spreading across the different MPs surfaces, which suggested the presence of a strong 18 
interaction at the interface between the MPs and cells (Figure 4, bottom row). On the other hand, the 19 
cells co-cultured with the unmodified PLGA MPs were attached to the tissue culture plastic and 20 
displayed typical 2D monolayer flat morphologies (Figure 4, top row).  21 
Therefore, we postulated that the cell attachment to the surface of the PLGADMAE MPs was most 22 
probably due to the presence of a weak electrostatic interaction between the positively charged 23 
DMAE functional groups available on the surface of the PLGADMAE MPs and the polyanionic cell 24 
membranes. The lack of any cell adhesion moieties on the unmodified PLGA MPs resulted in poor or 25 
no cell adhesion. This confirms the hypothesis that the PLGADMAE MPs readily promoted the 1 
attachment of the clinically relevant ADSCs at physiological condition.  2 
 3 
Figure 4: ADSCs readily adhere to PLGADMAE microparticles and show differential cellular 4 
morphologies when compared to ADSCs co-cultured with unmodified PLGA microparticles. 5 
Representative SEM images of ADSCs co-cultured with PLGA microparticles (top) or PLGADMAE 6 
microparticles (bottom). All scale bars are 100 µm. 7 
Next, to evaluate the degradation profile and morphology of the PLGA and PLGADMAE MPs, we 8 
resuspended the MPs in PBS (pH 7.4 and at 37 oC) and samples were taken for analysis at days 7, 14, 9 
and 21 post incubation. First, SEM imaging was used to observe the changes to the morphology of the 10 
MPs, namely changes that occur due to surface and bulk erosion. To demonstrate these changes to 11 
the surface and bulk of the MPs, SEM images were taken at low and high magnifications, respectively. 12 
In addition, GPC profiles were also monitored to characterize the changes to the molecular weight and 13 
molecular weight distributions. As shown in (Figure 5, A), on day 7 of incubation, the morphologies of 14 
the PLGA and PLGADMAE MPs were broadly similar. However, SEM images taken on day 14 and 21 15 
showed the appearance of deformation and coalescence in the structures of PLGADMAE MPs. 16 
Concomitant with this was presence of larger pore sizes across the surfaces and bulk of the MPs, 17 
indicating ongoing surface degradation. In contrast, the PLGA MPs preserved their spherical 18 
morphologies at day 14 and 21 but showed early signs of surface erosion indicated by the appearance 19 
of surface cracking. However, no sign of bulk erosion among the PLGA MPs was observed.  20 
The recorded GPC profiles for the samples analyzed from the cultured PLGA MPs, (Figure 5, Bi), 1 
showed a shift in the molecular weight from a unimodal (at day 0) to a bimodal (at day 7, 14 and 21) 2 
distribution, suggesting a slow and partial reduction in the molecular weight from a higher to a lower 3 
range. However, the GPC profile for the PLGADMAE MPs showed faster and more uniform degradation 4 
as depicted by the persistence of a unimodal distribution throughout the study (Figure 5, Bii). This was 5 
also supported by the calculated number average molecular weight values that showed a faster 6 
reduction in the molecular weight of the PLGADMAE compared to that of the PLGA MPs.  7 
The differences observed in the macroscopic and molecular degradation profiles between PLGA and 8 
PLGADMAE MPs were expected. This is because there are many reported factors that can affect the 9 
hydrolytic degradation of the polyester polymers, including polymer structure, molecular weight, 10 
crystallinity, as well as hydrophilicity of the terminal functional groups, which is more relevant to this 11 
work[30-32]. Therefore, we postulated that the insertion of the hydrophilic DMAE groups into the 12 
terminal structure of the PLGA polymers was responsible for enhanced molecular degradation of the 13 
PLGADMAE polymer compared to that of the unmodified PLGA. Similarly, the morphological changes 14 
observed with the PLGADMAE MPs were most likely due to enhanced water diffusion and thus increased 15 
accessibility of water molecules to weak and hydrolytically labile ester bonds. Nonetheless, the overall 16 
benefit of faster degradation of the PLGADMAE MPs compared to unmodified PLGA may depend on the 17 




Figure 5: PLGADMAE microparticles degrade more rapidly and uniformly than unmodified PLGA 2 
microparticles. (A) SEM of PLGA and PLGADMAE microparticles immersed in PBS at 37oC at days 7, 14, 3 
and 21 after incubation. Scale bars are 100 µm (high magnification) or 10 µm (low magnification). (B) 4 
Normalised GPC chromatograms, recorded with Refractive Index detector, depicting the shift in the 5 
molecular weight over time for (i) PLGA and (ii) PLGADMAE MPs.  6 
Taken together, this study presents a simple one-step strategy to prefunctionalise polyester polymers 7 
so to produce biomaterials with enhanced cell surface attachments at physiological conditions. This 8 
strategy also eliminates the requirement for laborious and extensive post-functionalization processes. 1 
The PLGADMAE MPs presented in this work readily attached to the clinically relevant cell type, ADSCs, 2 
maintained low toxicity and displayed more uniform degradation profiles compared to PLGA.  3 
Conclusions  4 
In this work, we introduced a new strategy to prefunctionalise hydrolytically degradable polyester 5 
polymers with cell adhesive moieties to address the shortcoming of these polymers intended for 6 
advanced biomedical applications. We validated the prefunctionalization method by synthesizing 7 
PLGA polymers with DMAE groups using a standard ROP technique. The introduction of the DMAE 8 
groups into the PLGA polymers did not change the bulk or thermal properties of the polymers. We 9 
also demonstrated the successful fabrication of MPs via a membrane emulsion technique. 10 
Furthermore, we showed that the clinically relevant ADSCs more readily attach to the surface of these 11 
MPs at physiological conditions, compared to no or poor attached unmodified PLGA MPs. We also 12 
assessed the impact of the prefunctionalization strategy on the degradation profile of the polymers. 13 
The introduction of the DMAE group elicited a faster and more uniform degradation of the PLGADMAE 14 
polymer. Importantly, we demonstrated that PLGADMAE MPs maintained the already desirable low 15 
cytotoxicity profile associated with PLGA MPs. This data set validates the prefunctionalization strategy 16 
and could be widely used to develop other hydrolytically degradable polyesters with a broad range of 17 
advanced biomedical applications.  18 
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